Genmab A/S
GMAB
$22.25
$0.050.23%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 42.52% | 78.41% | 13.27% | 24.52% | 10.33% |
| Total Depreciation and Amortization | 37.17% | 62.04% | 8.02% | 20.86% | 72.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -39.20% | -84.25% | 46.83% | -16.34% | 110.07% |
| Change in Net Operating Assets | 40.58% | -155.74% | -1,142.50% | -40.60% | -242.49% |
| Cash from Operations | 45.15% | 5.22% | 10.92% | 14.71% | -11.15% |
| Capital Expenditure | 17.15% | 49.33% | 60.45% | 42.43% | 17.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 252.58% | 371.96% | 442.22% | 196.69% | -47.36% |
| Cash from Investing | -220.23% | -666.92% | -964.98% | -192.60% | -36.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 47.95% | 57.14% | 30.43% | 32.26% | 6.41% |
| Issuance of Common Stock | -44.96% | -48.03% | -75.24% | -78.80% | -56.57% |
| Repurchase of Common Stock | -2,377.94% | -417.09% | -412.95% | -129.69% | 91.25% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -485.84% | -547.97% | -760.96% | -236.92% | 55.11% |
| Foreign Exchange rate Adjustments | 351.82% | 237.46% | 15.68% | 36.77% | -405.19% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -252.07% | -206.85% | -308.79% | -766.77% | -35.27% |